NeuroVita

NeuroVita is a Moscow-based clinical hospital and biotechnology research center specializing in personalized regenerative medicine and neuro-oncology. Founded in 2002 by Professor Andrey Bryukhovetskiy, the company focuses on the development and clinical application of innovative cell therapies, including hematopoietic and neural stem cell treatments for spinal cord injuries, traumatic brain injuries, and malignant tumors. NeuroVita's proprietary platforms integrate genomics, proteomics, and immunotherapy to provide tailored treatments for intractable neurological and oncological conditions. The hospital operates on the premises of the N.N. Blokhin National Medical Research Center of Oncology and holds over 30 patents for its unique biomedical technologies, such as artificial neural tissue and precision onco-immunotherapy.